Women's Cancer Research Foundation
Malnutrition As A Risk Factor for Post-operative Morbidity in Gynecologic Cancer
An article from Gynecologic Oncology reviewed the association between various malnutrition definitions with post-operative morbidity.
top of page
The Way Forward Is Clearer, Together.
The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.
Search
Women's Cancer Research Foundation
- Jul 28, 2022
- 2 min
Risk of Cancer after Premenopausal Bilateral Oophorectomy
Women undergoing hysterectomy are commonly offered a bilateral oophorectomy for ovarian and breast cancer prevention.
Women's Cancer Research Foundation
- Jul 26, 2022
- 2 min
Prevention of Ovarian Cancer
Risk reduction for women who carry BRCA1/2 mutations can achieve a 95% reduced risk of ovarian cancer through a risk-reducing...
Women's Cancer Research Foundation
- Jul 20, 2022
- 1 min
Liquid Biopsy in Ovarian Cancer
In recent years there have been considerable efforts to develop a blood test or liquid biopsy...
Women's Cancer Research Foundation
- Jul 11, 2022
- 2 min
Risk of Peritoneal Cancer After Risk-Reducing Bilateral Salpingo-Oophorectomy for Women
The average lifetime risk of developing ovarian cancer risk for women who harbor a BRCA1 or BRCA2 pathogenic germline mutation is 44% & 17%
Women's Cancer Research Foundation
- Jul 6, 2022
- 2 min
Breast Cancer Surgery Choice May Affect Young Survivors’ Quality of Life
Women diagnosed with breast cancer who had one or both breasts surgically removed had lower scores on a quality-of-life survey.
Women's Cancer Research Foundation
- Jun 28, 2022
- 2 min
Daily Aspirin Offers No Benefit in Breast Cancer Survivors
A recent study reported that daily intake of aspirin does not appear to prevent a recurrence of invasive breast cancer.
Women's Cancer Research Foundation
- Jun 24, 2022
- 2 min
Impact of Care by Gynecologic Oncologists on Primary Ovarian Cancer Survival: Population-based Study
Prompt treatment of advanced-stage ovarian cancer by a gynecologic oncologist with a combination of surgery and chemotherapy is approved...
Women's Cancer Research Foundation
- Jun 15, 2022
- 2 min
Contraceptive Use and the Risk of Ovarian Cancer Among Women With a BRCA1 or BRCA2 Mutation
Women with a BRCA1 and BRCA2 mutation have a higher lifetime risk of developing ovarian cancer.
Women's Cancer Research Foundation
- May 20, 2022
- 1 min
Ovarian Cancer Incidence and Death in Women Undergoing Bilateral Salpingo-Oophorectomy
Magnitude of risk reduction obtained with bilateral salpingo-oophorectomy remains unclear and must be weighed against the potential risks of
Women's Cancer Research Foundation
- May 18, 2022
- 2 min
A 2022 Physician's Guide to Hopes and Challenges of Cervical Cancer Eradication
Each year more than 14,000 women in the United States will be diagnosed with cervical cancer and more than 4,000 people will die from it.
Women's Cancer Research Foundation
- May 16, 2022
- 2 min
When Ovarian Cancer Returns, Surgery May Be a Good Choice for Selected Patients
A recent clinical trial revealed that a secondary surgery followed by chemotherapy can improve survival compared to chemotherapy alone.
Women's Cancer Research Foundation
- Apr 25, 2022
- 2 min
New Drug Combination Shown to be Effective for Patients with Advanced Ovarian Cancer
Ovarian cancer is the most lethal gynecologic malignancy. Novel approaches for relapsed ovarian cancer are necessary to improve survival.
Women's Cancer Research Foundation
- Apr 22, 2022
- 2 min
Clinical Characteristics, Pregnancy Outcomes & Ovarian Function - A Retrospective Age-Matched Study
Researchers evaluated the prognosis and pregnancy outcomes of pregnancy-associated breast cancer, a rare disease with increasing incidence.
Women's Cancer Research Foundation
- Apr 19, 2022
- 1 min
Lighting the Way for Improved Detection of Ovarian Cancer
Pafolacianine, an imaging drug that can help surgeons identify ovarian cancer lesions, has recently been accorded FDA approval.
Women's Cancer Research Foundation
- Apr 11, 2022
- 1 min
Breast Cancer and Community-Based Oncology Depression Screening Program
Researchers sought to examine if a greater proportion of breast cancer referrals to behavioral health could be achieved for patients in...
Women's Cancer Research Foundation
- Apr 7, 2022
- 1 min
Cancer Risks Associated with BRCA1 and BRCA2 Pathogenic Variants
In a recent study, age-specific risk estimates of cancers, excluding breast and ovarian cancer, associated with pathogenic variants in...
Women's Cancer Research Foundation
- Apr 5, 2022
- 1 min
Human Papillomavirus Infection Determines Prognosis in Cervical Cancer
Clinical research has identified a strong association between the detection of human papillomavirus (HPV) and invasive cervical cancer...
Women's Cancer Research Foundation
- Mar 31, 2022
- 2 min
Breast Cancer 2021
Breast cancer incidence has recently increased by 0.5% per year in the US and remains the 2nd leading cause of cancer death in women.
Women's Cancer Research Foundation
- Mar 28, 2022
- 1 min
Breast Cancer Surveillance Following Ovarian Cancer in BRCA Mutation Carriers
Women with a BRCA 1 or 2 mutation carriers have an increased risk of developing breast cancer and ovarian cancer. However....
bottom of page